762 related articles for article (PubMed ID: 12496040)
1. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review.
Kaaks R; Lukanova A; Kurzer MS
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1531-43. PubMed ID: 12496040
[TBL] [Abstract][Full Text] [Related]
2. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
[TBL] [Abstract][Full Text] [Related]
3. Progestogen deficiency and endometrial cancer risk.
Schindler AE
Maturitas; 2009 Apr; 62(4):334-7. PubMed ID: 19231117
[TBL] [Abstract][Full Text] [Related]
4. Energy balance, physical activity, and cancer risk.
Fair AM; Montgomery K
Methods Mol Biol; 2009; 472():57-88. PubMed ID: 19107429
[TBL] [Abstract][Full Text] [Related]
5. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
[TBL] [Abstract][Full Text] [Related]
6. Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study.
Chang SC; Lacey JV; Brinton LA; Hartge P; Adams K; Mouw T; Carroll L; Hollenbeck A; Schatzkin A; Leitzmann MF
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):723-30. PubMed ID: 17416763
[TBL] [Abstract][Full Text] [Related]
7. Endogenous hormones and ovarian cancer: epidemiology and current hypotheses.
Lukanova A; Kaaks R
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):98-107. PubMed ID: 15668482
[TBL] [Abstract][Full Text] [Related]
8. Hormonal carcinogenesis and socio-biological development factors in endometrial cancer: a clinical review.
Tinelli A; Vergara D; Martignago R; Leo G; Malvasi A; Tinelli R
Acta Obstet Gynecol Scand; 2008; 87(11):1101-13. PubMed ID: 18607816
[TBL] [Abstract][Full Text] [Related]
9. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
[TBL] [Abstract][Full Text] [Related]
10. Association of endometrial cancer risk with a functional polymorphism (Asp(327)Asn) in the sex hormone-binding globulin gene.
Kataoka N; Cai Q; Xu WH; Xiang YB; Cai H; Zheng W; Shu XO
Cancer; 2007 Apr; 109(7):1296-302. PubMed ID: 17315164
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer and obesity.
La Guardia M; Giammanco M
Panminerva Med; 2001 Jun; 43(2):123-33. PubMed ID: 11449184
[TBL] [Abstract][Full Text] [Related]
12. Sex steroid hormones, sex hormone-binding globulin, and obesity in men and women.
Tchernof A; Després JP
Horm Metab Res; 2000; 32(11-12):526-36. PubMed ID: 11246820
[TBL] [Abstract][Full Text] [Related]
13. Endometrium in PCOS: Implantation and predisposition to endocrine CA.
Giudice LC
Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):235-44. PubMed ID: 16772154
[TBL] [Abstract][Full Text] [Related]
14. Obesity, hormones, and cancer.
Kirschner MA; Ertel N; Schneider G
Cancer Res; 1981 Sep; 41(9 Pt 2):3711-7. PubMed ID: 7260928
[TBL] [Abstract][Full Text] [Related]
15. Polycystic ovary syndrome and endometrial cancer.
Navaratnarajah R; Pillay OC; Hardiman P
Semin Reprod Med; 2008 Jan; 26(1):62-71. PubMed ID: 18181084
[TBL] [Abstract][Full Text] [Related]
16. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
[TBL] [Abstract][Full Text] [Related]
17. Physical activity and inactivity in relation to sex hormone, prolactin, and insulin-like growth factor concentrations in premenopausal women - exercise and premenopausal hormones.
Tworoger SS; Missmer SA; Eliassen AH; Barbieri RL; Dowsett M; Hankinson SE
Cancer Causes Control; 2007 Sep; 18(7):743-52. PubMed ID: 17549594
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer risk in the WHI study: the problem of obesity.
Kuhl H
Maturitas; 2005 May; 51(1):83-97. PubMed ID: 15883113
[TBL] [Abstract][Full Text] [Related]
19. Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial.
Chen C; Weiss NS; Stanczyk FZ; Lewis SK; DiTommaso D; Etzioni R; Barnett MJ; Goodman GE
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1410-6. PubMed ID: 14693730
[TBL] [Abstract][Full Text] [Related]
20. Case-control study of endogenous steroid hormones and endometrial cancer.
Potischman N; Hoover RN; Brinton LA; Siiteri P; Dorgan JF; Swanson CA; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Persky V; Lurain JR
J Natl Cancer Inst; 1996 Aug; 88(16):1127-35. PubMed ID: 8757192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]